Company
Physiomics PLC
LON:PYC
Physiomics PLC combines expertise across modelling & simulation, biostatistics, data science and bioinformatics, together with deep biology expertise, to help biotech and pharma companies streamline their drug development journeys. The company's approach is to help derive insight from all relevant and often disparate data in order to de-risk decision making and optimise research design across discovery, pre-clinical and clinical studies.
76 stories · page 1 of 4
Physiomics climbs on Cancer Research contract win
Physiomics climbed roughly 19% in early trading on Wednesday after announcing a new contract with Cancer Research UK
Archive
Kingfisher still taking bashing from Thursday's statement
A look at Friday's major share movers on the London Stock Exchange
Archive
Small Cap Wrap - ProPhotonix, Ariana Resources, AB Dynamics and more...
Physiomics* 1.5p £1.08m (LON:PYC) The oncology consultancy using mathematical models and its Virtual Tumour™ technology to support the development of cancer treatment regimens and personalised medicine solutions, has updated its shareholder
Archive
Proactive news snapshot: Seeing Machines, Xpediator, Physiomics...
A glance at some of the day's highlights from the Proactive Investors newswire
Physiomics traded in line with expectations
Its Virtual Tumour software predicts the effect of different combinations of drugs on whatever type of cancer a pharmaceutical company might be researching
Physiomics’ Virtual Tumour software starting to gain traction in world of oncology
Here we take a closer look at Physiomics, the AIM company that owns a piece of software called Virtual Tumour that predicts the effects of drugs on cancers
Physiomics wins fourth immune-oncology contract for virtual tumour software
The software will enable Wall Street-listed Bicycle Therapeutics to test its drugs on tumours in a virtual setting
Archive
Proactive news snapshot: Union Jack Oil, Oncimmune, Ariana Resources …
A glance at some of the day's highlights from the Proactive Investors newswire
Archive
Proactive news snapshot: NetScientific , Metal Tiger, ANGLE …
A glance at some of the day's highlights from the Proactive Investors newswire
Investments and investor services
ANGLE points upwards after successful breast cancer trial outcome
A look at the day's major movers, including Karelian, UniVision, Cambria Africa, Bagir, Nautilus Marine, Stride Gaming and Patagonia Gold
Investments and investor services
FTSE 100 closes down after latest Trump trade war stunt
The Dow Jones suffered a 300 point fall in the first half hour of trading